Jacob Agmon

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)

Uri Goldbourt, Solomon Behar, Henrietta Reicher-Reiss et al. · The American Journal of Cardiology · 1993 · 157 citations

Metabolic Syndrome, Secondary Prevention Trial, Cardiovascular Disease +8

Polymorphous ventricular tachycardia: Clinical features and treatment

Samuel Sclarovksy, Boris Strasberg, Ruben F. Lewin et al. · The American Journal of Cardiology · 1979 · 151 citations

Cardiomyopathy, Cardiovascular Disease, Polymorphous Ventricular Tachycardia +5

The head-up tilt table test in patients with syncope of unknown origin

Boris Strasberg, Eldad Rechavia, Alex Sagie et al. · American Heart Journal · 1989 · 134 citations

Upright Posture, Kinesiology, Unknown Origin +4

Amiodarone-induced polymorphous ventricular tachycardia

Samuel Sclarovsky, Ruben F. Lewin, Oscar H. Kracoff et al. · American Heart Journal · 1983 · 126 citations

Cardiomyopathy, Cardiogenic Shock, Cardiovascular Disease +6

Procainamide-lnduced polymorphous ventricular tachycardia

Boris Strasberg, Samuel Sclarovsky, Aex Erdberg et al. · The American Journal of Cardiology · 1981 · 118 citations

Cardiomyopathy, Cardiovascular Disease, Physiology +4